Shenglian Biotech
SSE · 688098
Market Cap$3.1B
Revenue$272.1M
Listed OnSSE
Ticker688098
CEO / ExecMr. Dongsheng Nie
HeadquartersShanghai
MarketMainland China
Websitewww.slbio.com.cn
Overview
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.